Key result
Surgical treatment for congenitally corrected transposition of the great arteries has shifted toward anatomic repair, requiring lifelong monitoring due to progressive right ventricular dysfunction.
Why the study?
Congenitally corrected transposition of the great arteries has a highly variable clinical presentation and nuanced management, with persistent questions regarding intervention timing, long-term medical therapy, and risk prediction.
Answers are grounded in this paper and cite their sources.
This narrative review highlights that patients with congenitally corrected transposition of the great arteries face long-term risks of systemic right ventricular dysfunction, tricuspid regurgitation, heart failure, and arrhythmias, necessitating lifelong monitoring and individualized surgical or medical management.
Congenitally corrected transposition of the great arteries is a rare congenital heart defect caused by abnormal looping of the developing heart that results in double discordance of the atrioventricular and ventriculoarterial connections. In these patients, blood will flow through the heart in a physiologically correct direction; however, the morphologic right ventricle becomes responsible for pumping blood to the systemic circulation. The tricuspid valve also becomes the systemic atrioventricular valve. This places patients at risk for progressive right ventricular dysfunction, tricuspid regurgitation, heart failure, arrhythmias, and atrioventricular block. The clinical presentation is highly variable, with some patients being diagnosed during infancy, while others remain asymptomatic and may be diagnosed in adulthood. Typically, the diagnosis is made using echocardiography as the main first-line imaging test. Management is nuanced and consists of surgical versus nonsurgical intervention. Surgical treatment has increasingly shifted from physiologic repair toward anatomic repair, including double-switch procedures that place the morphologic left ventricle in the systemic position. Despite major improvements in diagnosis and treatment, important questions remain about the best timing of intervention, long-term medical therapy, and risk prediction. Larger registries, prospective studies, improved imaging, and new biomarkers may help guide more individualized care and improve long-term outcomes for patients with congenitally corrected transposition of the great arteries. However, due to the high risk for deteriorating cardiac function and cardiac-related events, these patients should be carefully monitored for life.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) conducted a review in Congenitally corrected transposition of the great arteries. Surgical treatment for congenitally corrected transposition of the great arteries has shifted toward anatomic repair, requiring lifelong monitoring due to progressive right ventricular dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: